
The article details two options strategies for Exact Sciences (EXAS), currently at $47.60, offering potential yield enhancement or discounted share acquisition. Selling a cash-secured put at the $37.50 strike, 21% out-of-the-money, could yield 13.36% annualized with an 80% chance of expiring worthless, targeting a $36.25 effective cost basis. Alternatively, a covered call at the $55.00 strike, 16% out-of-the-money, offers an 18.70% total return if called away, or a 12.63% annualized premium if it expires worthless (64% probability), effectively boosting yield on existing EXAS holdings.
The provided information details two distinct options strategies for EXACT Sciences Corp. (EXAS), currently trading at $47.60 per share, designed to either generate income or establish a position at a discount. The first strategy involves selling a cash-secured put at the $37.50 strike, which is approximately 21% out-of-the-money. This approach provides the seller with a $1.25 premium, lowering the effective purchase price to $36.25 if assigned, or generating a 13.36% annualized yield if the option expires worthless, an event with a stated 80% probability. The second strategy is a covered call for existing shareholders, selling the $55.00 strike call for a $1.50 premium. This caps the total potential return at 18.70% if the stock is called away but provides a 12.63% annualized yield boost if the option expires worthless, which has a 64% probability. A key data point is the discrepancy in volatility metrics: the implied volatility for the put contract is high at 73%, significantly above the call's 56% and the stock's actual trailing twelve-month volatility of 52%. This volatility skew suggests the options market is pricing in a greater probability of a significant downside move, thereby increasing the premium compensation for sellers of puts.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment